ArticleJournal of neurology2026
Telehealth enabled neuropsychological testing (TENT): a new platform for examiner-led, digital cognitive assessment.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCognitive testing provides an essential marker of brain function. Despite the widespread availability of technology, cognitive testing in contemporary practice largely remains rooted in the manual administration and scoring of analog materials. Here we introduce telehealth enabled neuropsychological testing (TENT): browser-based, videoconference-integrated software for examiner-led cognitive assessment.
methodsTENT incorporates a battery of tasks assessing memory, language, processing speed, attention and executive functions. We used TENT to conduct remote, telehealth-based assessments in 531 healthy volunteers, and validated the software in a sample of 452 individuals with drug-resistant epilepsy (DRE) and 392 individuals with newly diagnosed seizures. TENT-acquired measures were compared against clinically acquired, in-person, traditional cognitive measures where available. Participant user experience feedback was obtained in a subset of participants.
resultsComparison of healthy volunteers and DRE participants yielded a pattern of cognitive compromise characteristic of chronic, drug-resistant epilepsy. TENT data was sensitive to demographic and clinical parameters (e.g., age, antiseizure medication load, lateralised structural pathology, age at seizure onset) known to affect aspects of cognition. Correlations between TENT data and reference in-person measures were comparable to published test-retest coefficients for the reference measures. Participant user experience was overall positive.
conclusionsTENT modernizes traditional neuropsychological testing by providing for human-led cognitive assessments that exploit the benefits of technology-assisted testing and can be used for remote assessment. It offers a modular, normed and standardized system applicable across a range of neuropsychological conditions, providing reach, convenience, efficiencies and data richness. This approach draws upon the strengths of the traditional assessment model while modernizing contemporary neuropsychological practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.